SCNI Cash From Operations

Annual CFO

-$9.38 M
-$2.12 M-29.14%

December 31, 2023

Summary

Performance

1-Year Change

-29.14%

3-Year Change

+58.41%

5-Year Change

+38.22%

15-Year Change

-224.46%

SCNI Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.04%
SCNI annual cash flow from operations is higher than 61.04% of companies in Healthcare sector

High & Low

All-time High

-$1.21 M

3-Year Low

-$9.38 M
SCNI annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SCNI previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 15, 2025
SCNI next annual earnings announcement is scheduled for May 15, 2025

OtherSCNIcash flowmetrics:

Annual CFI

-$637.00 K
SCNI annual cash flow from investing activities is -$637.00 thousand

Annual CFF

$1.09 M
SCNI annual cash flow from financing activities is $1.09 million

Annual FCF

-$10.02 M
SCNI annual free cash flow is -$10.02 million

Annual CAPEX

-
SCNI annual capital expenditures value is unknown

Quarterly CFO

-$2.04 M
-$280.00 K-15.93%

September 1, 2024

Summary

Performance

3-Month Change

-15.93%

1-Year Change

-39.3%

3-Year Change

-243.68%

5-Year Change

-243.68%

SCNI Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61%
SCNI quarterly cash flow from operations is higher than 61% of companies in Healthcare sector

High & Low

All-time High

-$267.50 K

3-Year Low

-$3.67 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
SCNI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 15, 2025
SCNI next earnings announcement is scheduled for May 15, 2025

OtherSCNIcash flowmetrics:

Quarterly CFI

-$4000.00
SCNI quarterly cash flow from investing activities is -$4000.00

Quarterly CFF

$8000.00
SCNI quarterly cash flow from financing activities is $8000.00

Quarterly FCF

-$2.04 M
SCNI quarterly free cash flow is -$2.04 million

Quarterly CAPEX

$4000.00
SCNI quarterly capital expenditures is $4000.00

TTM CFO

-$6.48 M
+$184.00 K+2.76%

September 1, 2024

Summary

Performance

3-Month Change

+2.76%

1-Year Change

+16.72%

3-Year Change

+10.75%

5-Year Change

+10.75%

SCNI TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

66.46%
SCNI TTM cash flow from operations is higher than 66.46% of companies in Healthcare sector

High & Low

All-time High

-$483.80 K

3-Year Low

-$9.38 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
SCNI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 15, 2025
SCNI next earnings announcement is scheduled for May 15, 2025

OtherSCNIcash flowmetrics:

TTM CFI

-$246.00 K
SCNI TTM cash flow from investing activities is -$246.00 thousand

TTM CFF

$1.44 M
SCNI TTM cash flow from financing activities is $1.44 million

TTM FCF

-$6.73 M
SCNI TTM free cash flow is -$6.73 million

TTM CAPEX

$10.00 K
SCNI TTM capital expenditures is $10.00 thousand

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

SCNI Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-29.1%-39.3%+16.7%
3 y3 years+58.4%-243.7%+10.8%
5 y5 years+38.2%-243.7%+10.8%

SCNI Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-29.1%at low-243.7%+44.4%-486.8%+30.9%
5 y5-year-29.1%+58.4%-243.7%+44.4%-486.8%+30.9%
alltimeall time-677.0%+58.4%-661.9%+80.5%-1240.2%+60.1%

Scinai Immunotherapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.04 M(+15.9%)
-$6.48 M(-2.8%)
Jun 2024
-
-$1.76 M(+20.2%)
-$6.67 M(-14.4%)
Mar 2024
-
-$1.46 M(+19.4%)
-$7.79 M(-17.0%)
Dec 2023
-$9.38 M(+29.1%)
-$1.23 M(-44.9%)
-$9.38 M(+7.2%)
Sep 2023
-
-$2.22 M(-22.7%)
-$8.75 M(+3.8%)
Jun 2023
-
-$2.88 M(-6.0%)
-$8.43 M(-8.6%)
Mar 2023
-
-$3.06 M(+415.9%)
-$9.22 M(+26.9%)
Dec 2022
-$7.26 M(-2.2%)
-$593.00 K(-68.8%)
-$7.26 M(+8.9%)
Sep 2022
-
-$1.90 M(-48.1%)
-$6.67 M(+39.9%)
Jun 2022
-
-$3.67 M(+231.7%)
-$4.77 M(+331.7%)
Mar 2022
-
-$1.10 M(-82.1%)
-$1.10 M(-90.8%)
Dec 2021
-$7.43 M(-67.1%)
-
-
Dec 2020
-$22.56 M(+1.4%)
-
-
Dec 2019
-$22.25 M(+46.5%)
-
-
Jun 2019
-
-$6.17 M(+69.2%)
-$11.98 M(-26.3%)
Mar 2019
-
-$3.65 M(+230.7%)
-$16.25 M(+7.0%)
Dec 2018
-$15.19 M
-$1.10 M(+3.7%)
-$15.19 M(+5.8%)
Sep 2018
-
-$1.06 M(-89.8%)
-$14.35 M(-0.0%)
Jun 2018
-
-$10.44 M(+305.0%)
-$14.36 M(+198.2%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$2.58 M(+858.4%)
-$4.82 M(+66.5%)
Dec 2017
-$2.89 M(+15.2%)
-$269.00 K(-74.8%)
-$2.89 M(-9.2%)
Sep 2017
-
-$1.07 M(+18.8%)
-$3.19 M(+33.6%)
Jun 2017
-
-$899.70 K(+37.5%)
-$2.38 M(+3.1%)
Mar 2017
-
-$654.40 K(+16.3%)
-$2.31 M(-7.9%)
Dec 2016
-$2.51 M(-4.6%)
-$562.50 K(+110.3%)
-$2.51 M(-7.8%)
Sep 2016
-
-$267.50 K(-67.7%)
-$2.72 M(-11.2%)
Jun 2016
-
-$827.80 K(-2.8%)
-$3.06 M(+2.6%)
Mar 2016
-
-$851.70 K(+10.0%)
-$2.99 M(+13.6%)
Dec 2015
-$2.63 M(+35.3%)
-$774.00 K(+26.8%)
-$2.63 M(+12.4%)
Sep 2015
-
-$610.50 K(-18.8%)
-$2.34 M(+7.0%)
Jun 2015
-
-$751.50 K(+52.1%)
-$2.19 M(+11.8%)
Mar 2015
-
-$494.10 K(+2.2%)
-$1.95 M(+0.5%)
Dec 2014
-$1.94 M(+61.0%)
-$483.70 K(+5.9%)
-$1.94 M(+33.1%)
Sep 2014
-
-$456.70 K(-12.2%)
-$1.46 M(+45.5%)
Jun 2014
-
-$520.40 K(+7.6%)
-$1.00 M(+107.6%)
Mar 2014
-
-$483.80 K
-$483.80 K
Dec 2013
-$1.21 M(-35.6%)
-
-
Dec 2012
-$1.88 M(-26.2%)
-
-
Dec 2011
-$2.54 M
-
-

FAQ

  • What is Scinai Immunotherapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics annual CFO year-on-year change?
  • What is Scinai Immunotherapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics quarterly CFO year-on-year change?
  • What is Scinai Immunotherapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics TTM CFO year-on-year change?

What is Scinai Immunotherapeutics annual cash flow from operations?

The current annual CFO of SCNI is -$9.38 M

What is the all time high annual CFO for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high annual cash flow from operations is -$1.21 M

What is Scinai Immunotherapeutics annual CFO year-on-year change?

Over the past year, SCNI annual cash flow from operations has changed by -$2.12 M (-29.14%)

What is Scinai Immunotherapeutics quarterly cash flow from operations?

The current quarterly CFO of SCNI is -$2.04 M

What is the all time high quarterly CFO for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high quarterly cash flow from operations is -$267.50 K

What is Scinai Immunotherapeutics quarterly CFO year-on-year change?

Over the past year, SCNI quarterly cash flow from operations has changed by -$575.00 K (-39.30%)

What is Scinai Immunotherapeutics TTM cash flow from operations?

The current TTM CFO of SCNI is -$6.48 M

What is the all time high TTM CFO for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high TTM cash flow from operations is -$483.80 K

What is Scinai Immunotherapeutics TTM CFO year-on-year change?

Over the past year, SCNI TTM cash flow from operations has changed by +$1.30 M (+16.72%)